Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries.

Grace E CookseyLeslie A HamiltonJames C McMillenJared H GriffardAnthony Shaun Rowe

Published in: Neurocritical care (2022)

This study demonstrated that PCC used for the treatment of factor Xa inhibitor-associated ICH related to mild TBI did not significantly impact the incidence or degree of hemorrhage progression, and PCC treatment did not result in increased thromboembolic events.

Keyphrases

traumatic brain injury
risk factors
white matter
brain injury
functional connectivity